CAJ | 학술논문

将符合条件的类风湿关节炎患者100例采用随机数字表分成单纯药物治疗组38例,综合治疗组62例,剔除退出病例后单纯药物治疗组32例,综合治疗组52例,分别于用药前和用药后6个月进行问卷调查.结果显示综合治疗组治疗6个月后和治疗前相比,在生理功能、社会功能、心理影响、健康自我认识能力四方面生存质量量表评分差值(分别为19.0±9.1,10.0±6.9,6.6±3.2,11.4±7.6),均明显高于单纯药物治疗组(分别为6.6±4.8,3.8±3.3,3.0±1.8,5.3±3.4),差异均有统计学意义(P<0.05).提示综合治疗可以明显提高类风湿关节炎患者的生存质量.
장부합조건적류풍습관절염환자100례채용수궤수자표분성단순약물치료조38례,종합치료조62례,척제퇴출병례후단순약물치료조32례,종합치료조52례,분별우용약전화용약후6개월진행문권조사.결과현시종합치료조치료6개월후화치료전상비,재생리공능、사회공능、심리영향、건강자아인식능력사방면생존질량량표평분차치(분별위19.0±9.1,10.0±6.9,6.6±3.2,11.4±7.6),균명현고우단순약물치료조(분별위6.6±4.8,3.8±3.3,3.0±1.8,5.3±3.4),차이균유통계학의의(P<0.05).제시종합치료가이명현제고류풍습관절염환자적생존질량.
One hundred patients with rheumatoid arthritis (RA) were randomly assigned to the medication group (n=38) or combined therapy group (n=62). The quality of life was investigated through the questionnaire before and after 6 months' therapy. Data showed that there was statistically significant difference between the two groups in physical, social, and emotional functions, and self-recognized health status (19.0±9.1 vs 6.6±4.8, 10.0±6.9 vs 3.8±3.3, 6.6±3.2 vs 3.0±1.8, and 11.4±7.6 vs 5.3±3.4) ( all P<0.05 ). Combined therapy could significantly improve the quality of life in RA patients.